CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
May 10, 2017 09:00 ET
|
CURE Pharmaceutical
Oxnard, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching and developing drug and...
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 09, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
May 03, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 03, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
CURE Pharmaceutical Announces Development and Licensing Deal with Redbarn Pet Products
March 29, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 29, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit
March 27, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board
March 23, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 23, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
CURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.
March 21, 2017 08:30 ET
|
CURE Pharmaceutical; Meroven, Ltd.
OXNARD, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City
March 16, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer
March 15, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products
March 13, 2017 16:15 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...